A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.

Saved in:
Bibliographic Details
Title: A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.
Authors: Kamal A; Conforma Therapeutics Corporation, 9393 Towne Centre Drive, Suite 240, San Diego, California 92121, USA., Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ
Source: Nature [Nature] 2003 Sep 25; Vol. 425 (6956), pp. 407-10.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/nature01913